
SBIR Triple Re-Uptake Inhibitors: Potential AntidepressantsAward last edited on: 2/25/08
Sponsored Program
SBIRAwarding Agency
NIH : NIMHTotal Award Amount
$250,000Award Phase
1Solicitation Topic Code
-----Principal Investigator
David PickarCompany Information
Gabriel Pharma LLC (AKA: Potomac Pharma LLC~David Pickar MD )
6500 Seven Locks Road Suite 220
Cabin John, MD 20818
Cabin John, MD 20818
(301) 263-1313 |
cpickar@gabrielpharma.com |
www.gabrielpharma.com |
Location: Single
Congr. District: 08
County: Montgomery
Congr. District: 08
County: Montgomery
Phase I
Contract Number: 1R43MH081365-01Start Date: 00/00/00 Completed: 00/00/00
Phase I year
2007Phase I Amount
$250,000Thesaurus Terms:
antidepressant, dopamine antagonist, dopamine transporter, drug design /synthesis /production, drug discovery /isolation, norepinephrine, pharmacokinetics, serotonin inhibitor, serotonin transporter, sympathetic block behavioral habituation /sensitization, chemical association, chemical synthesis, cytochrome P450, drug adverse effect, drug withdrawal, enzyme inhibitor, ion channel blocker, mental disorder chemotherapy, nonhuman therapy evaluation, operant conditioning, potassium channel, psychological reinforcement, psychopharmacology, stereoisomer cell line, laboratory mouse, laboratory rat
Phase II
Contract Number: ----------Start Date: 00/00/00 Completed: 00/00/00